Short-term loans (net of amortization of loan fees)
111,721
111,721
111,721
111,722
Sba loans
14,592
14,592
14,592
14,592
Derivative liabilities
0
0
0
29,322
Lease liabilities
0
0
0
4,906
Convertible note
0
101
6,363
9,182
Total current liabilities
1,219,174
1,135,826
1,015,670
945,963
Notes payable
-
-
-
0
Sba loans
249,500
249,500
249,500
249,500
Lease liabilities
-
-
-
0
Total long-term liabilities
249,500
249,500
249,500
249,500
Total liabilities
1,468,674
1,385,326
1,265,170
1,195,463
Authorized 10,000,000 shares of preferred stock, without par value, of which 2,500,000 shares have been designated series a convertible preferred stock (2,500,000 shares outstanding at february 28, 2026, and may 31, 2025) and 2,000 shares have been designated series b preferred stock (2,000 shares outstanding at february 28, 2026, and may 31, 2025)
0
0
0
0
Common stock, without par value 20,000,000,000 shares authorized, of which 11,626,749,347 shares were issued and outstanding at february 28, 2026, and may 31, 2025
0
0
0
0
Additional paid-in capital
4,719,318
4,719,318
4,719,318
4,719,318
Accumulated deficit
-6,186,448
-6,082,513
-5,965,546
-5,882,901
Total stockholders deficiency
-1,467,130
-1,363,195
-1,246,228
-1,163,583
Total liabilities and stockholders deficiency
1,544
22,131
18,942
31,880
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cannabis Bioscience International Holdings, Inc. (CBIH)
Cannabis Bioscience International Holdings, Inc. (CBIH)